Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03911700 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

Study acronym: PREVENT
StatusActive, Not Recruiting
PhaseNot applicable
SponsorC. R. Bard
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion moved earlier from Dec 2029 to Aug 2028
    • Enrollment closed, study ongoing
    • Trial sites reduced: 45 → 33 locations
    • Study completion moved earlier from Dec 2031 to Aug 2031
    v31
  2. Study sites: 44 to 45v30
  3. Eligibility criteria revisedv29
  4. Study sites: 43 to 44v28
  5. Study sites: 42 to 43v27
Show 25 earlier versionsHide 25 earlier versions
  1. Study sites: 41 to 42v26
  2. Study sites: 39 to 41v25
  3. Study sites: 38 to 39v24
  4. Study sites: 37 to 38
    • Primary completion date: Sep 2029 to Dec 2029
    • Study completion date: Sep 2031 to Dec 2031
    • Eligibility criteria expanded, about 1 word
    v23
  5. Primary completion date: Oct 2027 to Sep 2029
    • Study sites: 27 to 37
    • Study completion date: Oct 2029 to Sep 2031
    • Eligibility criteria expanded, about 4 words
    v22
  6. Site details revised at 7 of 27 sitesv21
  7. Study sites: 26 to 27v20
  8. Eligibility criteria revisedv19
  9. Site details revised at 2 of 26 sitesv18
  10. Site details revised at 2 of 26 sitesv17
  11. Site contacts updated at 1 of 26 sitesv16
  12. 2 versions Re-verified since Jul 27, 2022, no change to tracked fieldsv14-v15
  13. Study sites revised (26)v13
  14. Re-verified, no change to tracked fieldsv12
  15. Lead sponsor: [Redacted] to C. R. Bardv11 Show 5 more changesShow less
    • Trial status: Withheld to Recruiting
    • Primary completion date: Oct 2027
    • Study completion date: Oct 2029
    • Start date: Dec 12, 2019
    • Study title shortened, about 6 words
  16. 9 versions Re-verified since Jan 2, 2020, no change to tracked fieldsv2-v10
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
C. R. Bard
11 trials monitored
See 2 trials at risk
This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hernia in subjects at risk for incisional hernia after open midline laparotomy surgery.
Trial Details
NCT Number NCT03911700
Lead Sponsor C. R. Bard
Conditions
(from sponsor)		 Open Midline Laparotomy
Enrollment 477 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov